This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.

A new study finds that specific B-cell subsets at diagnosis may help predict remission in early rheumatoid arthritis, ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

According to an affidavit, Clemente Lopez Jr. admitted to "allowing these types of assaults" in recent months.

Genocury Biotech announces positive results from noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma: Shenzhen, China Friday, May 2, 2025, 15:00 ...

Cultivated meat is an emerging field of food technology, however, to make it viable, it is important to learn how to optimize ...

jetMESSENGER ® reagent considerably outstrips Lipofectamine ™ 2000 transfection reagent in T cells, reaching more elevated GFP expression while preserving cell integrity. In B cells, it shows superior ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Self-taught venom expert Tim Friede has voluntarily injected himself with snake venom 856 times across 18 years.

Thousands of regional Queenslanders will have better access to lifesaving treatment, with a lymphoma medication listed on the ...

The two companies have been working together since 2021 to explore opportunities for bringing cell-cultivated seafood to ...